Microbix Announces Annual and Special Meeting Voting Results

MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 27, 2024.

At the Meeting, 42.64% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolutions that were voted upon are set out in the Management Information Circular (the “Circular”) dated February 13, 2024. The Circular is available on the Company’s website (www.microbix.com) and on SEDAR+ (www.sedarplus.ca).

All of the board of directors nominees listed in the Circular were re-elected as directors of Microbix. Results of the vote were as follows:

Nominee	Votes For	% Votes For		Withheld	% Withheld
Peter M. Blecher	55,859,458	96.71%		1,901,312	3.29%
Mark A. Cochran	56,489,958	97.80%		1,270,812	2.20%
Vaughn C. Embro-Pantalony	56,144,894	97.20%		1,615,876	2.80%
Joseph D. Renner	56,477,458	97.78%		1,283,312	2.22%
Martin Marino	55,859,458	96.71%		1,901,312	3.29%
Cameron Groome	56,141,394	97.20%		1,619,376	2.80%
Jennifer Stewart	49,515,228	85.72%		8,245,542	14.28%

Shareholders also approved a resolution re-approving the Company’s stock option plan, with 95.43% of the votes cast in favour and a resolution re-appointing the Company’s auditors, Ernst & Young LLP, with 97.87% of the votes cast in favour.